211 related articles for article (PubMed ID: 8333253)
1. Immature neural tissue grafts in Parkinson's disease.
Widner H
Acta Neurol Scand Suppl; 1993; 146():43-5. PubMed ID: 8333253
[TBL] [Abstract][Full Text] [Related]
2. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
3. Update on fetal transplantation: the Swedish experience.
Lindvall O
Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
[TBL] [Abstract][Full Text] [Related]
4. A functional assessment of embryonic dopaminergic grafts in the marmoset.
Annett LE; Dunnett SB; Martel FL; Rogers DC; Ridley RM; Baker HF; Marsden CD
Prog Brain Res; 1990; 82():535-42. PubMed ID: 2127119
[No Abstract] [Full Text] [Related]
5. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
[No Abstract] [Full Text] [Related]
6. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
Kirik D; Björklund A
Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
[No Abstract] [Full Text] [Related]
7. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of neuronal grafts in Parkinson's disease.
Lindvall O
J Neurol; 1994 Dec; 242(1 Suppl 1):S54-6. PubMed ID: 7699411
[TBL] [Abstract][Full Text] [Related]
9. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
Lindvall O; Sawle G; Widner H; Rothwell JC; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden CD; Odin P
Ann Neurol; 1994 Feb; 35(2):172-80. PubMed ID: 8109898
[TBL] [Abstract][Full Text] [Related]
10. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals.
Freed CR; Breeze RE; Rosenberg NL; Schneck SA
Adv Neurol; 1993; 60():721-8. PubMed ID: 8420217
[No Abstract] [Full Text] [Related]
11. Cell transplantation: a future therapy for Parkinson's disease?
Lindvall O
Neurologia; 1994 Mar; 9(3):101-7. PubMed ID: 8204256
[No Abstract] [Full Text] [Related]
12. Hitchcock's experimental series of foetal implants for Parkinson's disease: co-grafting ventral mesencephalon and striatum.
Meyer CH; Detta A; Kudoh C
Acta Neurochir Suppl; 1995; 64():1-4. PubMed ID: 8748573
[TBL] [Abstract][Full Text] [Related]
13. Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
Subrt O; Tichy M; Vladyka V; Hurt K
Acta Neurochir Suppl (Wien); 1991; 52():51-3. PubMed ID: 1792967
[TBL] [Abstract][Full Text] [Related]
14. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue.
Cochen V; Ribeiro MJ; Nguyen JP; Gurruchaga JM; Villafane G; Loc'h C; Defer G; Samson Y; Peschanski M; Hantraye P; Cesaro P; Remy P
Mov Disord; 2003 Aug; 18(8):928-32. PubMed ID: 12889084
[TBL] [Abstract][Full Text] [Related]
15. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
[TBL] [Abstract][Full Text] [Related]
16. Transplantation therapy for Parkinson's disease.
Borlongan CV
Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
[TBL] [Abstract][Full Text] [Related]
17. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.
Peschanski M; Defer G; N'Guyen JP; Ricolfi F; Monfort JC; Remy P; Geny C; Samson Y; Hantraye P; Jeny R
Brain; 1994 Jun; 117 ( Pt 3)():487-99. PubMed ID: 8032859
[TBL] [Abstract][Full Text] [Related]
18. [The structural bases for the correction of disordered brain functions by the transplantation of dissociated embryonic nerve tissue].
Bystron' IP; Otellin VA
Fiziol Zh Im I M Sechenova; 1995 Apr; 81(4):91-5. PubMed ID: 7581582
[No Abstract] [Full Text] [Related]
19. Behavioural effects of intracerebral dopaminergic grafts after neonatal destruction of the mesencephalic dopaminergic system.
Abrous N; Choulli K; Simon H; Le Moal M; Herman JP
Prog Brain Res; 1990; 82():481-7. PubMed ID: 2127114
[No Abstract] [Full Text] [Related]
20. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
